Cargando…
Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer
Identification of the different elements intervening at the tumor microenvironment seems key to explain clinical evolution in several tumor types. In this study, a set of immune biomarkers (myeloid derived suppressor cells, regulatory T cells, and OX40 + and PD-1 + T lymphocytes counts) in periphera...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277895/ https://www.ncbi.nlm.nih.gov/pubmed/34257359 http://dx.doi.org/10.1038/s41598-021-93838-w |
_version_ | 1783722149943443456 |
---|---|
author | Palazón-Carrión, Natalia Jiménez-Cortegana, Carlos Sánchez-León, M. Luisa Henao-Carrasco, Fernando Nogales-Fernández, Esteban Chiesa, Massimo Caballero, Rosalía Rojo, Federico Nieto-García, María-Adoración Sánchez-Margalet, Víctor de la Cruz-Merino, Luis |
author_facet | Palazón-Carrión, Natalia Jiménez-Cortegana, Carlos Sánchez-León, M. Luisa Henao-Carrasco, Fernando Nogales-Fernández, Esteban Chiesa, Massimo Caballero, Rosalía Rojo, Federico Nieto-García, María-Adoración Sánchez-Margalet, Víctor de la Cruz-Merino, Luis |
author_sort | Palazón-Carrión, Natalia |
collection | PubMed |
description | Identification of the different elements intervening at the tumor microenvironment seems key to explain clinical evolution in several tumor types. In this study, a set of immune biomarkers (myeloid derived suppressor cells, regulatory T cells, and OX40 + and PD-1 + T lymphocytes counts) in peripheral blood of patients diagnosed with advanced breast cancer were analyzed along of first line antineoplastic therapy. Subsequently, a comparison between groups with clinical benefit versus progression of disease and with a healthy women cohort was executed. Results reflected that patients showed higher basal levels of myeloid derived suppressor cells (35.43, IR = 180.73 vs 17.53, IR = 16.96 cells/μl; p = 0.001) and regulatory T cells (32.05, IR = 29.84 vs 22.61, IR = 13.57 cells/μl; p = 0.001) in comparison with healthy women. Furthermore, an increase in the number of activated T lymphocytes (expressing OX40), a decrease of immune inhibitory cells (MDSCs and Tregs) and inhibited T lymphocytes (expressing PD-1) were observed along the treatment in patients with clinical benefit (p ≤ 0.001). The opposite trend was observed in the case of disease progression. These findings suggest that some critical immune elements can be easily detected and measured in peripheral blood, which open a new opportunity for translational research, as they seem to be correlated with clinical evolution, at least in ABC. |
format | Online Article Text |
id | pubmed-8277895 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-82778952021-07-15 Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer Palazón-Carrión, Natalia Jiménez-Cortegana, Carlos Sánchez-León, M. Luisa Henao-Carrasco, Fernando Nogales-Fernández, Esteban Chiesa, Massimo Caballero, Rosalía Rojo, Federico Nieto-García, María-Adoración Sánchez-Margalet, Víctor de la Cruz-Merino, Luis Sci Rep Article Identification of the different elements intervening at the tumor microenvironment seems key to explain clinical evolution in several tumor types. In this study, a set of immune biomarkers (myeloid derived suppressor cells, regulatory T cells, and OX40 + and PD-1 + T lymphocytes counts) in peripheral blood of patients diagnosed with advanced breast cancer were analyzed along of first line antineoplastic therapy. Subsequently, a comparison between groups with clinical benefit versus progression of disease and with a healthy women cohort was executed. Results reflected that patients showed higher basal levels of myeloid derived suppressor cells (35.43, IR = 180.73 vs 17.53, IR = 16.96 cells/μl; p = 0.001) and regulatory T cells (32.05, IR = 29.84 vs 22.61, IR = 13.57 cells/μl; p = 0.001) in comparison with healthy women. Furthermore, an increase in the number of activated T lymphocytes (expressing OX40), a decrease of immune inhibitory cells (MDSCs and Tregs) and inhibited T lymphocytes (expressing PD-1) were observed along the treatment in patients with clinical benefit (p ≤ 0.001). The opposite trend was observed in the case of disease progression. These findings suggest that some critical immune elements can be easily detected and measured in peripheral blood, which open a new opportunity for translational research, as they seem to be correlated with clinical evolution, at least in ABC. Nature Publishing Group UK 2021-07-13 /pmc/articles/PMC8277895/ /pubmed/34257359 http://dx.doi.org/10.1038/s41598-021-93838-w Text en © The Author(s) 2021, corrected publication 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Palazón-Carrión, Natalia Jiménez-Cortegana, Carlos Sánchez-León, M. Luisa Henao-Carrasco, Fernando Nogales-Fernández, Esteban Chiesa, Massimo Caballero, Rosalía Rojo, Federico Nieto-García, María-Adoración Sánchez-Margalet, Víctor de la Cruz-Merino, Luis Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer |
title | Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer |
title_full | Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer |
title_fullStr | Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer |
title_full_unstemmed | Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer |
title_short | Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer |
title_sort | circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277895/ https://www.ncbi.nlm.nih.gov/pubmed/34257359 http://dx.doi.org/10.1038/s41598-021-93838-w |
work_keys_str_mv | AT palazoncarrionnatalia circulatingimmunebiomarkersinperipheralbloodcorrelatewithclinicaloutcomesinadvancedbreastcancer AT jimenezcorteganacarlos circulatingimmunebiomarkersinperipheralbloodcorrelatewithclinicaloutcomesinadvancedbreastcancer AT sanchezleonmluisa circulatingimmunebiomarkersinperipheralbloodcorrelatewithclinicaloutcomesinadvancedbreastcancer AT henaocarrascofernando circulatingimmunebiomarkersinperipheralbloodcorrelatewithclinicaloutcomesinadvancedbreastcancer AT nogalesfernandezesteban circulatingimmunebiomarkersinperipheralbloodcorrelatewithclinicaloutcomesinadvancedbreastcancer AT chiesamassimo circulatingimmunebiomarkersinperipheralbloodcorrelatewithclinicaloutcomesinadvancedbreastcancer AT caballerorosalia circulatingimmunebiomarkersinperipheralbloodcorrelatewithclinicaloutcomesinadvancedbreastcancer AT rojofederico circulatingimmunebiomarkersinperipheralbloodcorrelatewithclinicaloutcomesinadvancedbreastcancer AT nietogarciamariaadoracion circulatingimmunebiomarkersinperipheralbloodcorrelatewithclinicaloutcomesinadvancedbreastcancer AT sanchezmargaletvictor circulatingimmunebiomarkersinperipheralbloodcorrelatewithclinicaloutcomesinadvancedbreastcancer AT delacruzmerinoluis circulatingimmunebiomarkersinperipheralbloodcorrelatewithclinicaloutcomesinadvancedbreastcancer AT circulatingimmunebiomarkersinperipheralbloodcorrelatewithclinicaloutcomesinadvancedbreastcancer |